Muscle Relaxation Therapy Market: Rise in Prevalence of Chronic Back Pain to Drive the Market
Muscle Relaxation Therapy Market: Introduction
Muscle relaxation drugs are a group of medicines used to reduce and relax tension in muscles during spasms, hyperreflexia, and muscle pain. Muscle relaxation therapy is also given to patients having problems in mobility and impairments. Professional physiotherapists efficiently diagnose and treat these medical conditions.
Read Report Overview - https://www.transparencymarketresearch.com/muscle-relaxation-therapy-market.html
Muscle relaxation drugs and therapy services are used in combination to improve functional ability of different body organs and simultaneously advance quality of life
Presently, two types of muscle relaxants are available in the market: direct acting and centrally acting. Neuromuscular blocking agents are also known as direct acting muscle relaxants. These act by interfering with the transmission of neurons at the neuromuscular junction end plate. Centrally acting muscle relaxants are termed as spasmolytic agents. Spasmolytic agents usually act by interfering with the stimulated pathway between spinal cord and brain.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75133
Similarly, during muscle relaxation physiotherapy, pressure is applied on soft tissues and joints by using devices or manually which enables their free movement. This increases blood circulation and relaxes muscles.
Key Drivers of Global Muscle Relaxation Therapy Market
The global muscle relaxation therapy market is projected to grow at a rapid pace in the next few years. Increase in geriatric population, rise in prevalence of chronic back pain, and surge in number of accidental injuries are anticipated to drive the global muscle relaxation therapy market in the near future. According to research findings by the WHO (2017), lifetime prevalence of lower back pain is projected to be 60% to 70% among the overall population in industrialized countries. Dantrolene, tizanidine, and baclofen are some of the FDA approved drugs used to treat spasticity. Methocarbamol, metaxalone, orphenadrine, carisoprodol, chlorzoxazone, and cyclobenzaprine are some of the drugs approved for muscle spasms.
Request for Analysis of COVID-19 Impact on Muscle Relaxation Therapy Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75133
Increase in the number of muscle relaxation physiotherapy services offered is expected to drive the global market in next few years. For example, oncology therapy is provided to patients suffering from cancer which relieves pain and improves quality of life.
However, side effects associated with muscle relaxant drugs and therapies such as sedation, dizziness, and discomfort are factors likely to restrain the global muscle relaxation therapy market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75133
North America to Hold Major Share of Global Muscle Relaxation Therapy Market
North America dominates the global muscle relaxation therapy market due to advancements in health care & technologies, high adoption rate, and high per capita income. Additionally, increase in number of surgical procedures in the U.S. which can increase the chances of developing chronic lower back problems is expected to drive the muscle relaxation therapy market in North America. According to research reports published by the National Center for Complementary and Integrative Health (2017), more than 100 million adults in the U.S. experienced musculoskeletal pain disorder in 2016.
Asia Pacific is likely to be the most lucrative market for muscle relaxation therapy in the near future due to rapidly developing medical & technological infrastructure and increase in government initiatives
Pre Book Muscle Relaxation Therapy Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=75133<ype=S
Key Players Operating in Global Market
The global muscle relaxation therapy market is highly saturated, with key manufacturers implementing various strategies to gain maximum share
Leading players operating in the global muscle relaxation therapy market are:
- Abbott Laboratories
- Pfizer, Inc.
- Valeant Pharmaceutical International, Inc.
- Acorda Therapeutics, Inc.
- Merck & Co., Inc.
- AmeriCare Physical Therapy
- FullMotion Physical Therapy
- Minsu Healing Oasis LLC
Browse More Trending Reports by Transparency Market Research:
Dermatology Examination Tables Market: https://www.transparencymarketresearch.com/dermatology-examination-tables-market.html
Disposable Medical Gloves Market: https://www.transparencymarketresearch.com/disposable-medical-gloves-market.html
Miniature Retinal Scanners Market: https://www.transparencymarketresearch.com/miniature-retinal-scanners-market.html
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Mr. Rohit Bhisey
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453